Ask AI
ProCE Banner Activity

Omicron Subvariant Therapeutic Updates

Multimedia
Hear expert insights on ivermectin as a treatment for COVID-19 and evolving information on monoclonal antibodies during the latest omicron wave.

Released: June 07, 2022

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD

Director, Doherty Institute
Melbourne Laureate Professor
University of Melbourne
Consultant Infectious Diseases Physician
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.